Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Schroff KC, Aschhoff S, Schulze J, Nägele U, Remien J. A new method for recording surface compound potentials in sympathetic ganglia from mouse, rat, and guinea pig--application to muscarinic and nicotinic depolarizations. J Pharmacol Toxicol Methods 1999;41:189-94. [PMID: 10691025 DOI: 10.1016/s1056-8719(99)00040-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]

For:	Schroff KC, Aschhoff S, Schulze J, Nägele U, Remien J. A new method for recording surface compound potentials in sympathetic ganglia from mouse, rat, and guinea pig--application to muscarinic and nicotinic depolarizations. J Pharmacol Toxicol Methods 1999;41:189-94. [PMID: 10691025 DOI: 10.1016/s1056-8719(99)00040-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]

Number	Cited by Other Article(s)
1	Schulze J, Toepfer M, Schroff KC, Aschhoff S, Remien J, Müller-Felber W, Endres S. Clindamycin and nicotinic neuromuscular transmission. Lancet 1999;354:1792-3. [PMID: 10577648 DOI: 10.1016/s0140-6736(99)02881-0] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Abstract Upon clindamycin treatment a patient with Parkinson's disease showed marked tremor improvement which may be explained by clindamycin's ability to inhibit in-vitro nicotinergic, but not muscarinic signal transmission. Collapse Key Words Collapse MESH Headings Animals Anti-Bacterial Agents/therapeutic use Clindamycin/therapeutic use Diabetes Mellitus, Type 2/complications Humans Mice Parkinson Disease/complications Parkinson Disease/drug therapy Receptors, Muscarinic/drug effects Receptors, Nicotinic/drug effects Signal Transduction/drug effects Synaptic Transmission/drug effects Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Schulze J, Toepfer M, Schroff KC, Aschhoff S, Remien J, Müller-Felber W, Endres S. Clindamycin and nicotinic neuromuscular transmission. Lancet 1999;354:1792-3. [PMID: 10577648 DOI: 10.1016/s0140-6736(99)02881-0] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]